Comments to FDA: Probiotics Labeling Share page: Docket Number: FDA-2011-D-0376 Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics). Download Document Issues: Dietary Supplements Probiotics Other Issues Labeling Related Posts Comments Comments Regarding Provisions Pertaining to Preventing Access to U.S. Sensitive Personal Data and Government-Related Data Nov 28, 2024 Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024 Polibrief Weight Loss Products Nov 20, 2024